Alexandra MacLean
CIK: 0001940880
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATXI
AVENUE THERAPEUTICS, INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
About MacLean Alexandra
MacLean Alexandra (SEC CIK 0001940880) files insider reports with the SEC as Chief Executive Officer of AVENUE THERAPEUTICS, INC. (ATXI).
Signal8 holds 1 ownership filing by MacLean Alexandra, a Form 4, filed on Sep 25, 2024. Those filings report 1 transaction, the latest on Sep 23, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on MacLean Alexandra's filings is in BAY HARBOR ISLANDS, FL.
Recent filings by MacLean Alexandra
- Sep 23, 2024: Grant or award of ATXI shares (Form 4, code A).
Other insiders filing for AVENUE THERAPEUTICS, INC. (ATXI)
- Fortress Biotech, Inc., 10% Owner
- Herskowitz Neil, Director
- KRANZLER JAY D, Director
- ROSENWALD LINDSAY A MD, Director
- Oltmans Curtis Gale, Director
- Jin David, Interim PFO and COO